MedTrace Logo

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

NCT06546267 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2025-06-11

No results posted yet for this study

Summary

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024.

Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022

Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024

Conditions

Interventions

RADIATION

Image Guided Radiotherapy

Patients treated with IGRT for Prostate cancer will be evaluated

RADIATION

Intensity Modulated Radiotherapy

Patients treated with IMRT for Prostate cancer will be evaluated

RADIATION

Stereotactic Body Radiotherapy

Patients treated with SBRT for Prostate cancer will be evaluated

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Nadia G Di Muzio, Prof · IRCCS San Raffaele, Milan

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2026-02-14
Completion
2027-12-14

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546267 on ClinicalTrials.gov